{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:32:07Z","timestamp":1793381527725,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001825","name":"Danish Agency for Science, Technology and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007398","name":"Danish Council for Strategic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The ORBI Risk Score predicts in-hospital cardiogenic shock after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI). Whether high-risk patients also have more systemic inflammation, larger infarcts, and higher long-term mortality is not known.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In a DANAMI-3 sub-study, 1574 STEMI patients without cardiogenic shock were classified as high (ORBI \u22658, n = 273) or low risk (n = 1301). Inflammation was assessed by routine C-reactive protein (CRP), leucocyte count, and neutrophil-to-lymphocyte ratio (NLR) within 72\u2005h of PCI, and admission mid-regional pro-adrenomedullin (MR-proADM). Infarct size was measured by cardiac magnetic resonance. Ten-year all-cause mortality was obtained from the Danish Civil Registration System. Cox models were adjusted for age, sex, comorbidity, kidney function, and randomized allocation. High-risk patients had higher peak CRP (72 vs. 11\u2005mg\/L), leucocyte count (12.8 vs. 10.4 \u00d7 109\/L), NLR (6.2 vs. 3.5), and MR-proADM (0.73 vs. 0.62\u2005nmol\/L; all P &amp;lt; 0.001), as well as larger infarcts (final infarct size 15.7% vs. 10.1% of left ventricular mass). Ten-year mortality was 41% vs. 20% [hazard ratio (HR) 2.56, 95% CI 2.05\u20133.20; adjusted 1.47, 1.16\u20131.85]. The adjusted HR was 4.79 within 30 days and 1.27 after the first year. The score discriminated 10-year mortality less well than age alone (area under the curve 0.67 vs. 0.79).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The ORBI Risk Score identifies STEMI patients with more inflammation, larger infarcts, and higher mortality, especially in the first year. Beyond the first year, the association was largely explained by age. Whether anti-inflammatory treatment benefits these patients is a question for randomized trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjacc\/zuag126","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:50:46Z","timestamp":1790855446000},"source":"Crossref","is-referenced-by-count":0,"title":["Inflammation, infarct size, and 10-year mortality in STEMI patients stratified by the ORBI Risk Score: a DANAMI-3 sub-study"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0793-4557","authenticated-orcid":false,"given":"Joakim Bo","family":"Kunkel","sequence":"first","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4693-8980","authenticated-orcid":false,"given":"Jacob","family":"L\u00f8nborg","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1543-8948","authenticated-orcid":false,"given":"Martin","family":"Frydland","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]},{"name":"Zealand University Hospital, Department of Cardiology , Roskilde ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7279-970X","authenticated-orcid":false,"given":"Burcu Tas","family":"\u00d6zbek","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1821-9428","authenticated-orcid":false,"given":"Lars","family":"Nepper-Christensen","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5362-8593","authenticated-orcid":false,"given":"Niels","family":"Vejlstrup","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-0202","authenticated-orcid":false,"given":"Kiril Aleksov","family":"Ahtarovski","sequence":"additional","affiliation":[{"name":"Zealand University Hospital, Department of Cardiology , Roskilde ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6635-1466","authenticated-orcid":false,"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7609-4141","authenticated-orcid":false,"given":"Dan Eik","family":"H\u00f8fsten","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2299-7377","authenticated-orcid":false,"given":"Jasmine Melissa","family":"Marquard","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3692-4491","authenticated-orcid":false,"given":"Utsho","family":"Islam","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8426-617X","authenticated-orcid":false,"given":"Sarah Louise Duus","family":"Holle","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5094-4809","authenticated-orcid":false,"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0941-378X","authenticated-orcid":false,"given":"Lene","family":"Holmvang","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-0981","authenticated-orcid":false,"given":"Christian","family":"Hassager","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]},{"name":"University of Copenhagen, Department of Clinical Medicine , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5436-9194","authenticated-orcid":false,"given":"Thomas","family":"Engstr\u00f8m","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]},{"name":"University of Copenhagen, Department of Clinical Medicine , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-0898","authenticated-orcid":false,"given":"Helle","family":"S\u00f8holm","sequence":"additional","affiliation":[{"name":"Rigshospitalet\u2014Copenhagen University Hospital, Department of Cardiology , Blegdamsvej 9, Copenhagen DK-2100 ,","place":["Denmark"]},{"name":"Sk\u00e5ne University Hospital, Department of Cardiology , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"key":"2026103013014762700_zuag126-B1","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/eurheartj\/ehv428","article-title":"Cardiovascular disease in Europe\u2014epidemiological update 2015","volume":"36","author":"Townsend","year":"2015","journal-title":"Eur Heart J"},{"key":"2026103013014762700_zuag126-B2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jama.2010.1139","article-title":"System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention","volume":"304","author":"Terkelsen","year":"2010","journal-title":"JAMA"},{"key":"2026103013014762700_zuag126-B3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4244\/EIJ-D-17-00857","article-title":"Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy","volume":"14","author":"Nepper-Christensen","year":"2018","journal-title":"EuroIntervention"},{"key":"2026103013014762700_zuag126-B4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ejhf.1750","article-title":"Trends in cardiogenic shock complicating acute myocardial infarction","volume":"22","author":"Aissaoui","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026103013014762700_zuag126-B5","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1093\/eurheartj\/ehy127","article-title":"Predicting the development of in-hospital cardiogenic shock in patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score","volume":"39","author":"Auffret","year":"2018","journal-title":"Eur Heart J"},{"key":"2026103013014762700_zuag126-B6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1186\/s13063-024-08573-0","article-title":"Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): study protocol","volume":"25","author":"Kunkel","year":"2024","journal-title":"Trials"},{"key":"2026103013014762700_zuag126-B7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1186\/s13063-024-08567-y","article-title":"Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial): study protocol","volume":"25","author":"Holle","year":"2024","journal-title":"Trials"},{"key":"2026103013014762700_zuag126-B8","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.jacc.2026.01.019","article-title":"Effect of tocilizumab on pro-B-type natriuretic peptide and infarct size in patients with acute myocardial infarction at risk of cardiogenic shock (DOBERMANN-T)","volume":"87","author":"Kunkel","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"2026103013014762700_zuag126-B9","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.jacc.2026.01.020","article-title":"Effect of low-dose dobutamine infusion on N-terminal pro-B-type natriuretic peptide in at-risk patients with acute myocardial infarction (DOBERMANN-D)","volume":"87","author":"Holle","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"2026103013014762700_zuag126-B10","first-page":"356","article-title":"Basic mechanisms in cardiogenic shock: part 1\u2014definition and pathophysiology","volume":"11","author":"Krychtiuk","year":"2022","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026103013014762700_zuag126-B11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/eurheartj\/ehp070","article-title":"C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction","volume":"30","author":"\u00d8rn","year":"2009","journal-title":"Eur Heart J"},{"key":"2026103013014762700_zuag126-B12","first-page":"640","article-title":"Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction","volume":"6","author":"Reindl","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026103013014762700_zuag126-B13","doi-asserted-by":"crossref","first-page":"e008123","DOI":"10.1161\/JAHA.117.008123","article-title":"MR-proADM as a prognostic marker in patients with ST-segment-elevation myocardial infarction\u2014DANAMI-3 substudy","volume":"7","author":"Falkentoft","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026103013014762700_zuag126-B14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12872-018-0812-6","article-title":"Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"2026103013014762700_zuag126-B15","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026103013014762700_zuag126-B16","doi-asserted-by":"crossref","first-page":"e014941","DOI":"10.1161\/JAHA.119.014941","article-title":"Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction","volume":"9","author":"Abbate","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026103013014762700_zuag126-B17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamacardio.2017.0022","article-title":"Effect of ischemic postconditioning during primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: a randomized clinical trial","volume":"2","author":"Engstr\u00f8m","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026103013014762700_zuag126-B18","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(16)30072-1","article-title":"Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial","volume":"387","author":"Kelb\u00e6k","year":"2016","journal-title":"Lancet"},{"key":"2026103013014762700_zuag126-B19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial","volume":"386","author":"Engstr\u00f8m","year":"2015","journal-title":"Lancet"},{"key":"2026103013014762700_zuag126-B20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ahj.2015.02.004","article-title":"The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only: rationale and design of the DANAMI 3 trial program","volume":"169","author":"H\u00f8fsten","year":"2015","journal-title":"Am Heart J"},{"key":"2026103013014762700_zuag126-B21","doi-asserted-by":"crossref","first-page":"e003588","DOI":"10.1136\/openhrt-2025-003588","article-title":"Ten-year target lesion failure in patients treated with primary PCI: results from DANAMI-3","volume":"12","author":"\u00d6zbek","year":"2025","journal-title":"Open Heart"},{"key":"2026103013014762700_zuag126-B22","doi-asserted-by":"crossref","first-page":"e004823","DOI":"10.1161\/JAHA.116.004823","article-title":"Left ventricular hypertrophy is associated with increased infarct size and decreased myocardial salvage in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"6","author":"Nepper-Christensen","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026103013014762700_zuag126-B23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"2026103013014762700_zuag126-B24","doi-asserted-by":"publisher","DOI":"10.1159\/000552034","article-title":"A risk score without a window: the clinical timing problem of ORBI (Observatoire R\u00e9gional Breton sur l'Infarctus) risk score","author":"Holle","year":"2026","journal-title":"Cardiology"},{"key":"2026103013014762700_zuag126-B25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)","volume":"333","author":"Fox","year":"2006","journal-title":"BMJ"},{"key":"2026103013014762700_zuag126-B26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2026103013014762700_zuag126-B27","doi-asserted-by":"crossref","first-page":"131610","DOI":"10.1016\/j.ijcard.2023.131610","article-title":"Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction","volume":"398","author":"Moroni","year":"2024","journal-title":"Int J Cardiol"},{"key":"2026103013014762700_zuag126-B28","doi-asserted-by":"crossref","first-page":"e14110","DOI":"10.1111\/eci.14110","article-title":"Pathogenic pathways and therapeutic targets of inflammation in heart diseases: a focus on interleukin-1","volume":"54","author":"Del Buono","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"2026103013014762700_zuag126-B29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","article-title":"Inflammation in acute myocardial infarction: the good, the bad and the ugly","volume":"45","author":"Matter","year":"2024","journal-title":"Eur Heart J"},{"key":"2026103013014762700_zuag126-B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2019.04.064","article-title":"Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI","volume":"289","author":"Laursen","year":"2019","journal-title":"Int J Cardiol"}],"container-title":["European Heart Journal: Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjacc\/advance-article-pdf\/doi\/10.1093\/ehjacc\/zuag126\/71575888\/zuag126.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/advance-article-pdf\/doi\/10.1093\/ehjacc\/zuag126\/71575888\/zuag126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:01:54Z","timestamp":1793379714000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/advance-article\/doi\/10.1093\/ehjacc\/zuag126\/8860181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":30,"URL":"https:\/\/doi.org\/10.1093\/ehjacc\/zuag126","relation":{},"ISSN":["2048-8726","2048-8734"],"issn-type":[{"value":"2048-8726","type":"print"},{"value":"2048-8734","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"article-number":"zuag126"}}